- Home
- / Boryung Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Boryung Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₩10.9 K
2024-10-29
Market Capitalization
₩723.2 B
2024-10-29
Revenue
₩1 T
FY, 2025
CreditSafe Score
?
Score changed on Jun 11, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 460.4B | 524.3B | 561.9B | 627.3B | 760.5B | 859.6B | 1.0T | 1.0T |
| Cost of goods sold | 243.2B | 269.0B | 280.0B | 315.7B | 392.6B | 482.0B | 631.3B | 621.4B |
| Gross profit | 222.2B | 255.5B | 282.5B | 312.3B | 368.3B | 377.8B | 386.1B | 397.5B |
| Gross profit margin, % | 48.3% | 48.7% | 50.3% | 49.8% | 48.4% | 43.9% | 38.0% | 39.1% |
| Operating expense total | 176.1B | 199.0B | 215.1B | 238.9B | 274.7B | 265.0B | 272.5B | 287.4B |
| Depreciation and amortization | 16.1B | 17.2B | 26.8B | 31.3B | 38.4B | 44.4B | 48.0B | 43.9B |
| EBITDA | 42.6B | 62.0B | 67.5B | 98.9B | 89.7B | 108.7B | 109.4B | 108.8B |
| EBITDA margin, % | 9.3% | 11.8% | 12.0% | 15.8% | 11.8% | 12.7% | 10.8% | 10.7% |
| EBIT | 26.0B | 42.9B | 40.1B | 65.0B | 48.9B | 61.6B | 59.1B | 61.6B |
| EBIT margin, % | 5.6% | 8.2% | 7.1% | 10.4% | 6.4% | 7.2% | 5.8% | 6.1% |
| Interest income | 165.0M | 16.2M | 482.1M | 1.4B | 4.5B | 871.8M | 6.0B | 8.6B |
| Interest expense | 96.5M | 62.1M | 3.3B | 4.5B | 6.1B | 9.5B | 9.0B | 11.6B |
| Pre tax profit | 26.6B | 42.5B | 36.0B | 70.7B | 58.9B | 56.3B | 63.0B | 69.8B |
| Income tax expense | 6.3B | 10.2B | 9.2B | 27.6B | 16.9B | 16.1B | (6.7B) | 5.5B |
| Net Income | 20.3B | 32.2B | 26.9B | 43.1B | 41.9B | 40.2B | 69.6B | 64.3B |